A F Hofmann. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Allylamine/analogs & derivativesAllylamine/therapeutic useAnti-Bacterial Agents/adverse effectsBile Acids and Salts/metabolismCholagogues and Choleretics/therapeutic useCholestasis/complicationsCholestasis/metabolismColesevelam HydrochlorideHumansPruritus/drug therapyPruritus/etiologyRifampin/adverse effects
Substances: See more » Anti-Bacterial AgentsBile Acids and SaltsCholagogues and CholereticsAllylamineColesevelam HydrochlorideRifampin
Year: 2002 PMID: 12377823 PMCID: PMC1773428 DOI: 10.1136/gut.51.5.756
Source DB: PubMed Journal: Gut ISSN: 0017-5749 Impact factor: 23.059